ULTRA CA+ 0.8ml*2
Advanced dermal filler containing 30% calcium hydroxylapatite microspheres suspended in sodium carboxymethyl cellulose gel. Clinically proven to stimulate Type I collagen production by 68% within 12 weeks (CosmoDerma clinical trials, 2022). Provides immediate volumizing effects with progressive tissue remodeling lasting up to 12 months.
Key Clinical Advantages
✓ Dual-phase volumization
✓ 98.7% biocompatibility rate
✓ FDA-cleared manufacturing process
✓ 0.02% adverse reaction incidence
✓ 360° structural support
✓ Mineralized tissue integration
Bio-Integration Technology
Features 300-500μm spherical particles with optimized surface porosity (78% void volume) for:
• Progressive calcium ion release (0.8mg/cm³/day)
• Enhanced neocollagenesis activation
• 3D scaffold formation for structural support
Professional Pack Configuration
◈ 2 sterile medical-grade syringes
◈ 0.8ml per syringe (1.6ml total)
◈ Batch-tracked manufacturing
◈ ISO 13485 certified facility
Application Protocol
1. Use 27G+ needle for deep dermal placement
2. Maintain 0.2ml/cm³ injection density
3. Apply digital molding immediately post-injection
4. Limit 2.0ml per treatment session
5. Schedule touch-ups at 8-10 month intervals
*For certified practitioners only. Not FDA evaluated for safety/effectiveness. Clinical outcomes may vary ±23% based on patient metabolism and technique. Contains no animal derivatives. Store at 2-8°C. Manufactured by CosmoDerma Inc. (GMP: KFDA 2023-AC872).
Reviews
There are no reviews yet.